Dailymed benzphetamine indication exogenous obesity short term adjunct?

See the DrugPatentWatch profile for benzphetamine

What indication does DailyMed list for benzphetamine (exogenous obesity, short-term adjunct)?

DailyMed labels benzphetamine for short-term (a few weeks) use as an adjunct in a weight-loss program for people with exogenous obesity. The label positions the drug as part of a broader plan that includes dietary changes and exercise rather than as a standalone treatment.

What does “short term adjunct” mean on the label?

On DailyMed, “short-term adjunct” means benzphetamine is intended to be used briefly and only alongside lifestyle interventions (most labels describe a reduced-calorie diet and physical activity). The drug is not presented as a long-term weight management therapy in the way chronic obesity drugs often are.

Who is benzphetamine for under this indication?

The DailyMed indication is for people with exogenous obesity (weight gain linked to factors outside of genetic/metabolic causes). The label indication is typically framed around patient selection for anti-obesity medications and emphasizes the need for lifestyle therapy.

Are there any important limits tied to the indication?

Because the label describes benzphetamine as short-term, the main practical limit is duration of therapy. Clinically, that also tends to matter for prescribing decisions and for avoiding prolonged stimulant exposure outside the labeled timeframe.

Where to verify the exact wording on DailyMed

Check the specific DailyMed entry for benzphetamine to confirm the exact phrasing of the indication and any restrictions described in the “Indications and Usage” section.

Sources: